Treatment Patterns for Patients on Overactive Bladder Therapy: A Retrospective Statistical Analysis Using Canadian...

Area of Science:

• Pharmacology
• Urology
• Health Services Research

Background:

• Overactive bladder (OAB) significantly impacts quality of life, with antimuscarinic drugs being a primary treatment.
• Poor persistence and adherence limit the effectiveness of current OAB pharmacotherapies.
• Limited data exist on OAB treatment switching and factors influencing discontinuation.

Purpose of the Study:

• To analyze discontinuation rates of antimuscarinic medications in new OAB patients.
• To examine switching patterns to alternative OAB medications.
• To assess the influence of age, gender, and initial drug choice on discontinuation.

Main Methods:

• Retrieved Canadian prescription data from IMS Brogan for 31,754 patients over four years.
• Tracked medication usage from an index claim, with primary endpoint as days to discontinuation.
• Utilized Kaplan-Meier and Cox proportional hazards models for analysis.

Main Results:

• A high discontinuation rate of approximately 91% was observed within four years.
• Initial oxybutynin use was associated with lower retention compared to other antimuscarinics.
• Women were more likely to switch treatments than men; only 12.5% switched medication.

Conclusions:

• Initial antimuscarinic therapy for OAB shows high discontinuation rates.
• Several antimuscarinics demonstrate lower discontinuation risks than oxybutynin.
• Most patients do not progress to second-line OAB treatments.